Truninger K, Attenhofer Jost C H, Seifert B, Vogt P R, Follath F, Schaffner A, Jenni R
Department of Internal Medicine, University Hospital Zurich, Raemistrasse 100, 8091 Zurich, Switzerland.
Heart. 1999 Dec;82(6):714-20. doi: 10.1136/hrt.82.6.714.
To identify predictors for the safe use of antibiotic treatment without reoperation in patients with prosthetic valve endocarditis.
Retrospective study in a tertiary care centre.
All 49 episodes of definite prosthetic valve endocarditis (Duke criteria) diagnosed at one institution between 1980 to 1997 were analysed. Ten episodes (20%) were treated with antibiotics only (antibiotic group) and 39 episodes (80%) with combined antibiotic and surgical treatment (surgery group). The analysis included detailed study of hospital records and data on long term follow up which were obtained in all patients by a questionnaire or telephone contact with physician or patient. The length of follow up (mean (SD)) was 41 (32) months in the antibiotic group and 45 (24) months in the surgery group (NS). Long term survival was estimated by the Kaplan-Meier method and compared by the log-rank test.
There was no significant difference in age, history of previous endocarditis, number of previous heart operations, vegetations, emboli, type of prosthesis, or percentage of early prosthetic valve endocarditis and positive blood cultures between the two groups. In the antibiotic group, there were more enterococcal (50%; p = 0.005) and in the surgery group more staphylococcal infections (55%; p = 0.048). Annular abscesses (p < 0. 0001) and aortoventricular dehiscence (p = 0.02) were more common in the surgery group. No patient in the antibiotic group had heart failure. Long term follow up showed no significant difference between the surgery and antibiotic groups regarding late mortality (14% v 18%) and five year rates of recurrent endocarditis (14% v 16%), event related mortality (14% v 3%, log-rank test), and the need for reoperation (14% v 19%; log-rank test). The only patient with conservatively treated staphylococcal prosthetic valve endocarditis died after reoperation for recurrence.
Haemodynamically stable patients with non-staphylococcal prosthetic valve endocarditis who are carefully supervised can be treated with antibiotics alone without an increased rate of reinfection, reoperation, or death.
确定人工瓣膜心内膜炎患者安全使用抗生素治疗而无需再次手术的预测因素。
在一家三级医疗中心进行的回顾性研究。
分析了1980年至1997年间在一家机构诊断出的49例明确的人工瓣膜心内膜炎(杜克标准)病例。其中10例(20%)仅接受抗生素治疗(抗生素组),39例(80%)接受抗生素与手术联合治疗(手术组)。分析包括对医院记录的详细研究以及通过问卷调查或与医生或患者电话联系获取的所有患者的长期随访数据。抗生素组的随访时间(均值(标准差))为41(32)个月,手术组为45(24)个月(无显著差异)。采用Kaplan-Meier法估计长期生存率,并通过对数秩检验进行比较。
两组在年龄、既往心内膜炎病史、既往心脏手术次数、赘生物、栓子、人工瓣膜类型、早期人工瓣膜心内膜炎百分比及血培养阳性方面无显著差异。抗生素组肠球菌感染更多(50%;p = 0.005),手术组葡萄球菌感染更多(55%;p = 0.048)。手术组瓣周脓肿(p < 0.0001)和主动脉瓣心室分离(p = 0.02)更常见。抗生素组无患者发生心力衰竭。长期随访显示,手术组和抗生素组在晚期死亡率(14%对18%)、复发性心内膜炎的五年发生率(14%对16%)、事件相关死亡率(14%对3%,对数秩检验)及再次手术需求(14%对19%;对数秩检验)方面无显著差异。唯一接受保守治疗的葡萄球菌人工瓣膜心内膜炎患者在因复发再次手术后死亡。
血流动力学稳定的非葡萄球菌人工瓣膜心内膜炎患者,在严密监测下可单独使用抗生素治疗,而不会增加再感染、再次手术或死亡的发生率。